ConductScience.org, home

Paper40367177

Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy.

Zhang H and 8 others. Sci Adv, 2025. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy. Papers, record 40367177. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40367177

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy.
PubMed
Journal
Sci Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
14.21, provisional
iCite
Revised in PubMed
2025-05-16
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
NeoplasmsMajor topic
Photothermal TherapyMajor topic
NanoparticlesMajor topic
Animals
Mice
Humans
Cell Line, Tumor
Apoptosis

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135239514Targeting HIF-1α abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues.J Clin Invest2022https://conductscience.org/library/papers/35239514PubMed
229417106Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy.Chem Soc Rev2018https://conductscience.org/library/papers/29417106PubMed
337822154Mild-Photothermal Effect Induced High Efficiency Ferroptosis-Boosted-Cuproptosis Based on Cu2 O@Mn3 Cu3 O8 Nanozyme.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37822154PubMed
431990409Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications.Adv Mater2020https://conductscience.org/library/papers/31990409PubMed
534160201Upconverted Metal-Organic Framework Janus Architecture for Near-Infrared and Ultrasound Co-Enhanced High Performance Tumor Therapy.ACS Nano2021https://conductscience.org/library/papers/34160201PubMed
623890059Oncology meets immunology: the cancer-immunity cycle.Immunity2013https://conductscience.org/library/papers/23890059PubMed
732929201PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.Nat Cell Biol2020https://conductscience.org/library/papers/32929201PubMed
834865269Guiding Transition Metal-Doped Hollow Cerium Tandem Nanozymes with Elaborately Regulated Multi-Enzymatic Activities for Intensive Chemodynamic Therapy.Adv Mater2022https://conductscience.org/library/papers/34865269PubMed
936995655Ultra-Small High-Entropy Alloy Nanoparticles: Efficient Nanozyme for Enhancing Tumor Photothermal Therapy.Adv Mater2023https://conductscience.org/library/papers/36995655PubMed
1028516983Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Chem Soc Rev2017https://conductscience.org/library/papers/28516983PubMed
1133420008Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress.Nat Commun2021https://conductscience.org/library/papers/33420008PubMed
1233522578Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer.Acta Biochim Biophys Sin (Shanghai)2021https://conductscience.org/library/papers/33522578PubMed
1327668797Nanomedicine: An iron age for cancer therapy.Nat Nanotechnol2016https://conductscience.org/library/papers/27668797PubMed
1436527888Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade.Drug Resist Updat2023https://conductscience.org/library/papers/36527888PubMed
1535154485Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.Theranostics2022https://conductscience.org/library/papers/35154485PubMed
1633789692Ultrasound targeted microbubble destruction combined with Fe-MOF based bio-/enzyme-mimics nanoparticles for treating of cancer.J Nanobiotechnology2021https://conductscience.org/library/papers/33789692PubMed
1732312987Transformable hybrid semiconducting polymer nanozyme for second near-infrared photothermal ferrotherapy.Nat Commun2020https://conductscience.org/library/papers/32312987PubMed
1824943004Solvothermal synthesis of ternary Cu2 MoS4 nanosheets: structural characterization at the atomic level.Small2014https://conductscience.org/library/papers/24943004PubMed
1934932846Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics.Angew Chem Int Ed Engl2022https://conductscience.org/library/papers/34932846PubMed
2035028603Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.Cell Rep Med2021https://conductscience.org/library/papers/35028603PubMed

See all 54 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
42862494Copper single-atom carbon dots hydrogel resets oxidative and immune homeostasis for rheumatoid arthritis therapy.Discov Nano2026https://conductscience.org/library/papers/42862494PubMed
42860524An ATP7A-Mediated Endogenous Regulation Bio-Clay Enzyme Enables Self-Amplified Copper Accumulation for Immunogenic Pyrop.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42860524PubMed
42846706Nanozymes in Tumor Microenvironment Modulation for Cancer Therapy.Biomater Res2026https://conductscience.org/library/papers/42846706PubMed
42699616Photocontrolled nanosystem potentiates photo-chemoimmunotherapy against TNBC by integrating apoptosis/ferroptosis/ pyroptosis and STING activation.Mater Today Bio2026https://conductscience.org/library/papers/42699616PubMed
42645179Experimental Detection Methods and Clinical Translational Challenges of Disulfidptosis in Cancer.Cells2026https://conductscience.org/library/papers/42645179PubMed
42502487Precise Catalysis and Immune Activation: New Strategies for Tumor Immunotherapy with Cascade Nanozymes.Int J Nanomedicine2026https://conductscience.org/library/papers/42502487PubMed
42473554Nanozyme-Driven Ferroptosis-Cuproptosis Interplay in Lung Cancer.Int J Nanomedicine2026https://conductscience.org/library/papers/42473554PubMed
42467272Bacteria mediated tumor therapy recent advances challenges and future perspectives.Discov Oncol2026https://conductscience.org/library/papers/42467272PubMed
42454093Bimetallic nanozymes with galvanic cell effects eradicate intratumoral bacteria and tumor cells to overcome drug resistance and potentiate antitumor immune responses for tumor therapy.Bioact Mater2026https://conductscience.org/library/papers/42454093PubMed
42436485A novel pH-responsive nanoreactor for pyroptosis induction: multifaceted ROS amplification drives potent immunotherapy against triple-negative breast cancer.J Nanobiotechnology2026https://conductscience.org/library/papers/42436485PubMed
42382257Photo-responsive nanozymes: from photocatalytic mechanisms to precision therapy.Front Chem2026https://conductscience.org/library/papers/42382257PubMed
42376249Recent advances in engineered nanozymes for precision lung cancer therapy.Mater Today Bio2026https://conductscience.org/library/papers/42376249PubMed
42374476Targeting AIF to trigger RIPKs/MLKL necroptosis: a disulfiram-based strategy to reverse paclitaxel resistance in ovarian cancer.Cell Commun Signal2026https://conductscience.org/library/papers/42374476PubMed
42316280Chemotactic Gold Nanozyme-Powered Flasklike Pentosan Nanobots for Tumor-Specific Drug Delivery.Adv Healthc Mater2026https://conductscience.org/library/papers/42316280PubMed
42178870From Cold to Hot: Nanozyme-Based Strategies for Reprogramming the Tumour Immunoenvironment.Cell Prolif2026https://conductscience.org/library/papers/42178870PubMed
42178559Self-fueling catalysis-driven membrane destabilization triggers CSC-enriched tumors ablation.J Nanobiotechnology2026https://conductscience.org/library/papers/42178559PubMed
42168999A multimodal ROS generation and bimodal ferroptosis and cuproptosis self-reinforced strategy for effective bone metastases therapy.J Nanobiotechnology2026https://conductscience.org/library/papers/42168999PubMed
42160094Bandgap-Engineered PtxTey:Ag2Te Composite Quantum Dots Enable Programmable NIR-II Imaging and Photothermal-Immune Synergistic Therapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42160094PubMed
42151972A MOF-in-MOF nanoplatform for photothermal/chemodynamic therapy that enhances antitumor immunity through targeted suppression of the COX-2/PGE2 axis.J Nanobiotechnology2026https://conductscience.org/library/papers/42151972PubMed
42144539Piezoelectric Nanozymes With Acoustically Rejuvenated Catalytic Activities Rewire Lipid Metabolism for Two-Pronged Ferroptotic Therapy.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42144539PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40367177

GET https://conductscience.org/api/papers/v1/40367177/references?page=2